Author: Abdelgawad, Noha
Author: Abdelwahab, Mahmoud Tareq
Similar Items: Pharmacokinetics, pharmacogenetics and optimisation of treatment with non-nucleoside reverse transcriptase inhibitors in HIV-infected African children
- Pharmacometrics of dolutegravir and tenofovir: a quantitative approach to characterise drug-drug interactions, pharmacogenetics and optimise treatment
- Lead optimisation of an indole based HIV-1 non-nucleoside reverse transcriptase inhibitor
- Indole- and diaryl ether-derived non-nucleoside reverse transcriptase inhibitors
- Efavirenz pharmacogenetics and metabolic toxicity in black South Africans
- Population pharmacokinetic and pharmacodynamic modelling to improve tuberculosis treatment
- The rational design and synthesis of novel HIV non-nucleoside reverse transcriptase inhibitors
Similar Items: Population/ Nonlinear mixed-effects modelling of pharmacokinetics and pharmacodynamics of tuberculosis treatment
- In vivo Pharmacodynamic and Pharmacokinetic Interactions of Hibiscus sabdariffa Calyces Extracts with Simvastatin
- Pharmacometrics to characterize pharmacokinetics and optimize treatment in understudied populations
- Investigating the effects of treatment in HIV disease models
- The determination and validation of population pharmacokinetic parameters of phenytoin in adult epileptic patients in the Western Cape using nonlinear mixed-effects modelling
- Population pharmacokinetic and pharmacodynamic modelling to improve tuberculosis treatment
- Characterizing population pharmacokinetic/pharmacodynamic relationships in pulmonary tuberculosis infected adults using nonlinear mixed effects modelling